Welcome to our dedicated page for elf Beauty SEC filings (Ticker: ELF), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The e.l.f. Beauty, Inc. (NYSE: ELF) SEC filings page on Stock Titan provides direct access to the company’s regulatory disclosures, along with AI-powered summaries to help interpret key information. As a public beauty company with a multi-brand portfolio that includes e.l.f. Cosmetics, e.l.f. SKIN, Keys Soulcare, Well People, Naturium and rhode, e.l.f. Beauty uses its SEC filings to report financial performance, acquisitions, governance matters and other material events.
Among the most relevant documents for ELF investors are its annual reports on Form 10-K and quarterly reports on Form 10-Q, which detail net sales, margins, expenses, liquidity, debt levels and risk factors. For example, the company’s earnings press releases referenced in Form 8-K filings discuss net sales growth across retailer and e-commerce channels, changes in gross margin, SG&A trends, adjusted EBITDA and net income, as well as outlook for future periods. Stock Titan’s AI tools can highlight the sections that matter most, such as segment performance and non-GAAP reconciliations, without requiring readers to parse every line.
Current reports on Form 8-K are especially important for tracking material events at e.l.f. Beauty. Recent 8-K filings describe the completion of the acquisition of HRBeauty LLC (rhode), the establishment of a new term loan facility under an amended credit agreement, and the issuance of earnings press releases. An 8-K/A provides the required financial statements and pro forma information for the rhode acquisition. AI-generated overviews can explain the implications of these events, such as how new debt facilities and acquisitions may affect the company’s capital structure and brand portfolio.
Investors interested in governance and executive compensation can review e.l.f. Beauty’s definitive proxy statement (DEF 14A), which outlines items of business for the annual meeting, including director elections, advisory votes on executive compensation and auditor ratification. The proxy also discusses performance metrics, compensation design and the company’s perspective on its long run of net sales and market share growth.
In addition, Stock Titan surfaces insider transaction reports on Form 4 and other ownership-related filings when available, allowing users to monitor equity awards, stock sales or purchases by directors and executives. Real-time updates from EDGAR, combined with AI explanations, help investors quickly understand how each filing fits into the broader story of e.l.f. Beauty’s growth, financing activities and governance practices.
Form 144 notice for e.l.f. Beauty, Inc. (ELF) reports a proposed sale of 55,692 common shares through Morgan Stanley Smith Barney LLC on the NYSE, with an aggregate market value of $7,461,057.24 and approximately 56,734,903 shares outstanding. The approximate date of sale is 09/08/2025. The filing discloses the acquisition history for the shares to be sold: 26,634 shares from RSUs/RSAs acquired on 06/01/2024 and 29,058 shares from Performance Stock Units acquired on 04/21/2025. The filer reports no securities sold in the past three months and includes the standard representation that the seller is not aware of undisclosed material adverse information.
e.l.f. Beauty director Gayle Tait sold 565 shares of common stock on 08/28/2025 at $130.20 per share, reducing her direct holdings to 5,202 shares. The filing on Form 4 shows the sale was reported by an attorney-in-fact and the remaining beneficial ownership includes 1,633 restricted stock units specifically disclosed. The report identifies Tait as a director and indicates this Form 4 was filed by one reporting person. No derivative transactions or additional amendments are disclosed in the submission.
Maureen C. Watson, a director of e.l.f. Beauty, Inc. (ELF), reported a sale of 785 shares of the issuer's common stock on 08/28/2025 at a price of $128.3982 per share. After the reported transaction, she beneficially owned 2,745 shares in total, which the filing states includes 1,642 restricted stock units. The Form 4 was filed as a single reporting person report and signed by Scott K. Milsten as attorney-in-fact on 08/29/2025.
Form 144 notice for e.l.f. Beauty, Inc. (ELF) reports a proposed sale of 785 restricted common shares by the named person through Morgan Stanley Smith Barney on the NYSE, with an aggregate market value of $100,792.59 and an approximate sale date of 08/28/2025. The shares were acquired as restricted stock on 08/22/2024 and payment was recorded as not applicable.
The filing also discloses a prior sale by Maureen C. Watson of 3,875 common shares on 06/03/2025 generating gross proceeds of $445,625.00. The filer certifies no undisclosed material adverse information and includes the standard Rule 144 representations.
Form 144 notice for e.l.f. Beauty, Inc. (ELF): The filer proposes to sell 565 shares of common stock through Morgan Stanley Smith Barney (New York) on 08/28/2025 with an aggregate market value of $73,563.00. The issuer reports 56,734,903 shares outstanding. The securities were acquired as restricted stock on 08/22/2025 from the issuer and payment is recorded on 08/22/2025. The filer reports “Nothing to Report” for sales during the past three months and certifies no undisclosed material adverse information is known.
e.l.f. Beauty, Inc. (ELF) director received a grant of restricted stock units. The Form 4 filed for reporting person Gayle Tait shows a grant of 1,633 RSUs on 08/21/2025. Each RSU converts into one share when vested; the transaction price is reported as $0. After the reported grant, the filing shows the reporting person beneficially owns 5,767 shares in total. The filing is signed by an attorney-in-fact on behalf of Gayle Tait on 08/25/2025. The reporting person is identified as a director of the issuer.
Charles V. Bergh, a director of e.l.f. Beauty, Inc. (ELF), received a grant of 1,203 restricted stock units (RSUs) on 08/21/2025. Each RSU converts to one share upon vesting, and the reported transaction shows 1,203 RSUs acquired at a reported price of $0. After the grant, Mr. Bergh’s total beneficial ownership is reported as 2,056 shares (which includes the 1,203 RSUs). The Form 4 was signed by an attorney-in-fact on behalf of Mr. Bergh on 08/25/2025. This filing discloses a routine equity compensation award to a director and does not include exercise prices or vesting schedule details in the submitted content.
e.l.f. Beauty, Inc. (ELF) Form 4 disclosure: This filing reports a grant of 1,203 restricted stock units (RSUs) to Maria Ferreras, who is identified as a director of the company. Each RSU converts into one share of common stock upon vesting and the RSUs were reported with a transaction date of 08/21/2025 and zero cash price. After the reported transaction, the filing shows the reporting person beneficially owns 2,024 shares in total, which includes the 1,203 RSUs. The Form 4 was signed by an attorney-in-fact on behalf of Ms. Ferreras and is a routine insider reporting of equity compensation.
e.l.f. Beauty director Kenneth Mitchell received a grant of 1,676 restricted stock units (RSUs) on 08/21/2025. Each RSU converts to one share upon vesting and the reported grant was recorded with a $0 purchase price, indicating compensation rather than a cash purchase. After the award, the reporting person beneficially owns 17,847 shares in total. The Form 4 was signed by an attorney-in-fact on behalf of Mr. Mitchell on 08/25/2025 and lists his role as a director. The filing documents a routine equity compensation award to an insider and does not disclose vesting dates or additional terms for the RSUs.
e.l.f. Beauty director Lori Keith received a grant of 1,680 restricted stock units (RSUs) on 08/21/2025, each converting into one share upon vesting. The Form 4 shows the acquisition was reported as a non‑derivative transaction with a reported price of $0, and the reporting person's total beneficial ownership following the grant is 22,698 shares (which includes the 1,680 RSUs). The filing identifies Lori Keith as a director and was signed by an attorney‑in‑fact on 08/25/2025.